ES2152293T3 - Polipeptidos similares a la motilina con actividad estimuladora de la motilidad gastrointestinal. - Google Patents

Polipeptidos similares a la motilina con actividad estimuladora de la motilidad gastrointestinal.

Info

Publication number
ES2152293T3
ES2152293T3 ES94305707T ES94305707T ES2152293T3 ES 2152293 T3 ES2152293 T3 ES 2152293T3 ES 94305707 T ES94305707 T ES 94305707T ES 94305707 T ES94305707 T ES 94305707T ES 2152293 T3 ES2152293 T3 ES 2152293T3
Authority
ES
Spain
Prior art keywords
glu
leu
lys
gln
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94305707T
Other languages
English (en)
Inventor
Mark J Macielag
Ramalinga Dharanipragada
James R Florance
Mary Sue Marvin
Alphonse Galdes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of ES2152293T3 publication Critical patent/ES2152293T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/63—Motilins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ESTA INVENCION SE REFIERE A POLIPEPTIDOS QUE TIENEN UNA ACTIVIDAD DE ESTIMULACION MOTORA GASTROINTESTINAL REPRESENTADA POR LA FORMULA (1) DONDE A ES EL ESTEREOISOMERO L DE UN MINOACIDO ALICICLICO O ALIFATICO LIPOFILICO; B ES PROLINA L O ALANINA L; D ES ESTEREOISOMERO L DE UN AMINOACIDO ALICICLICO O ALIFATICO LIPOFILICO; E ES ESTEREOISOMERO L DE UN AMINOACIDO ALICICLICO O ALIFATICO LIPOFILICO AROMATICO; F ES EL ESTEREOISOMERO L DE UN AMINOACIDO HETEROAROMATICO O AROMATICO; G ES GLICINA O ALANINA D; H ES ACIDO GLUTAMICO L I O GLUTAMINA L; I ES GLUTAMINA L, ACIDO GLUTAMICO L O LANINA L; J ES UN ENLACE DIRECTO O SE ELIGE ENTRE EL GRUPO QUE CONSISTE EN Z, ZLEU, Z-LEU-GLN, A-LEU-GLN-GLU, Z-LEU-GLN-GLU-LYS, Z-LEU-GLN,GLU, L_YS, GLU, Z-LEU-GLN-GLU-LYS-GLU-ARG, Z-LEU-CLN,-GLU-LYS-GLU-ARG-ASN, Z-LEU-CLN,-GLU-LYS-GLU-ARG-ASN-LYS, Y Z-LEU-CLN,-GLU-LYS-GLU-ARGASN-LYS-GLY, DONDE Z ES ELEGIDA ENTRE EL GRUPO QUE CONSISTE EN ARGININA, ARGININA D, HOMOARGININA D, LISINA D, ORNITINA D, ACIDO 2,4-DIAMINOBUTIRICO D, GLUTAMINA D, ASPARAGINA D, ALANINA D; R1 ES ALQUILO INFERIOR O ALILO; R2 ES ELEGIDO EN EL GRUPO QUE CONSISTE EN HIDROGENO, ALQUILO INFERIOR, PROPARGILO, Y ALQUILO, R3 ES ELEGIDO EN EL GRUPO QUE CONSISTE EN ALQUILO INFERIOR, CICLOALQUILO, ARILO SUSTITUIDO E INSUSTITUIDO Y HETEROARILO, DONDE LOS SUBSTITUYENTES DE ARILO SE ELIGEN EN EL GRUPO QUE CONSISTE EN HALOGENO, HIDROXI Y ALCOXI INFERIOR; R6 ES ELEGIDO ENTRE EL GRUPO QUE CONSISTE EN CH2CONH2, GRUPOS AMINOALQUILO Y GRUPOS GUANINOALQUILO; R6 ES -COOH O -CONH2, Y M ESS 0 O 1 SIEMPRE QUE (A) CUANDO M ES 0, R2 Y R3 SON HIDROGENO, Y J ES UN ENLACE DIRECTO, EL GRUPO -NH-CH(CH2R5)R6 TIENE LA CONFIGURACION D; B) R5 ES -CH2CONH2 SOLAMENTE CUANDO J ES Z-LEU O Z-LEUGLN-GLU-LYS-ARG-ASN-LYS-GLY; C) CUANDO M=0, R2 Y R3 SON HIDROGENO Y J ES Z, Z-LEU-GLN-GLU.LYS-GLU-ARG, Z-LEU-GLN-GLU-LYSGLU-ARG-ASN, Z-LEU-GLN-GLU-LYS-GLU-ARG-ASN-LYS, Y Z-LEU-GLN-GLULYS-GLU-ARG-ASN-LYS,GLY, Z TIENE LA CONFIGURACION D; Y D) EL POLIPEPTIDO ES DISTINTO DE MOLITINO.
ES94305707T 1993-08-06 1994-08-01 Polipeptidos similares a la motilina con actividad estimuladora de la motilidad gastrointestinal. Expired - Lifetime ES2152293T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/103,490 US5422341A (en) 1993-08-06 1993-08-06 Motilin-like polypeptides with gastrointestinal motor stimulating activity

Publications (1)

Publication Number Publication Date
ES2152293T3 true ES2152293T3 (es) 2001-02-01

Family

ID=22295474

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94305707T Expired - Lifetime ES2152293T3 (es) 1993-08-06 1994-08-01 Polipeptidos similares a la motilina con actividad estimuladora de la motilidad gastrointestinal.

Country Status (15)

Country Link
US (1) US5422341A (es)
EP (1) EP0646601B1 (es)
JP (1) JP2949129B2 (es)
KR (1) KR100360975B1 (es)
CN (1) CN1054857C (es)
AT (1) ATE194627T1 (es)
AU (1) AU677324B2 (es)
CA (1) CA2127330C (es)
DE (1) DE69425212T2 (es)
DK (1) DK0646601T3 (es)
ES (1) ES2152293T3 (es)
FI (1) FI111462B (es)
NO (1) NO312299B1 (es)
TW (1) TW434261B (es)
ZA (1) ZA945436B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734012A (en) * 1996-05-16 1998-03-31 Ohmeda Pharmaceutical Products Division Inc. Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
IL140993A0 (en) * 2000-05-15 2002-02-10 Bayer Ag Trypsin substrate and diagnostic device, and method of using same
US20050009205A1 (en) * 2003-07-11 2005-01-13 Ye Fang Fluorescent ligands for GPCR arrays
US7521420B2 (en) 2003-06-18 2009-04-21 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor
US20060293243A1 (en) * 2005-06-17 2006-12-28 Navneet Puri Stable, buffered, pharmaceutical compositions including motilin-like peptides
US20060287243A1 (en) * 2005-06-17 2006-12-21 Navneet Puri Stable pharmaceutical compositions including motilin-like peptides
EP2054429B1 (en) 2006-09-11 2013-11-06 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
MY161842A (en) 2009-07-29 2017-05-15 Daiichi Sankyo Co Ltd Motilin-like peptide compound having transmucosal absorbability imparted thereto
CN107383169A (zh) * 2017-04-24 2017-11-24 青岛大学 一种具有胃肠运动刺激活性的多肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2753274B2 (ja) * 1988-08-24 1998-05-18 株式会社三和化学研究所 モチリン様ポリペプチドの製法並びにそのための組換えｄｎａ及び発現用プラスミド
EP0378078A1 (en) * 1989-01-06 1990-07-18 Sanwa Kagaku Kenkyusho Co., Ltd. Motilin-like polypeptide and use thereof
JPH02311495A (ja) * 1989-05-24 1990-12-27 Sanwa Kagaku Kenkyusho Co Ltd モチリン様活性を有するポリペプチド及びその用途
JPH04364131A (ja) * 1991-04-03 1992-12-16 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性モチリン製剤

Also Published As

Publication number Publication date
JP2949129B2 (ja) 1999-09-13
ZA945436B (en) 1995-04-04
KR100360975B1 (ko) 2003-01-24
CA2127330A1 (en) 1995-02-07
CN1119650A (zh) 1996-04-03
NO312299B1 (no) 2002-04-22
DE69425212D1 (de) 2000-08-17
TW434261B (en) 2001-05-16
FI943651A0 (fi) 1994-08-05
ATE194627T1 (de) 2000-07-15
KR950005320A (ko) 1995-03-20
DK0646601T3 (da) 2000-09-18
CN1054857C (zh) 2000-07-26
EP0646601B1 (en) 2000-07-12
FI111462B (fi) 2003-07-31
CA2127330C (en) 1998-07-14
DE69425212T2 (de) 2001-03-08
AU6596794A (en) 1995-02-16
US5422341A (en) 1995-06-06
EP0646601A1 (en) 1995-04-05
NO942690D0 (no) 1994-07-18
JPH0770178A (ja) 1995-03-14
AU677324B2 (en) 1997-04-17
FI943651A7 (fi) 1995-02-07
NO942690L (no) 1995-02-07

Similar Documents

Publication Publication Date Title
ES2152293T3 (es) Polipeptidos similares a la motilina con actividad estimuladora de la motilidad gastrointestinal.
ES2181006T3 (es) Uso de amidas de acidos de piridil alcanos, piridil alquenos y/o piridil alquinos en el tratamiento de tumores o en inmunosupresion.
CY1113218T1 (el) Υβριδιο και διμερης εκφραση πρωτεϊνων ναϊσσεριας
ATE423194T1 (de) Von-willebrand-faktor (vwf) spaltendes protease- polypeptid, für das polypeptid codierende nukleinsäure und verwendung des polypeptids
ES2087207T3 (es) Factor del crecimiento de fibroblasto quimerico.
FI20010060A7 (fi) 5-metoksi-indoli-3-karboksialdehydiamino-(pentyyliamino)metyleeni-hydratsoni
CO5060540A1 (es) Proceso para fabricar hipobromito de metal alcalino o alca- linoterreo estabilizado y usos del mismo en el tratamiento de aguas para controlar el ensuciamiento microbiano
SV1996000033A (es) Isotiazolonas
ATE405654T1 (de) Polypeptid mit verbesserter cytosin-deaminase- aktivität
DK0851925T3 (da) Humane Væksthormonvarianter
DK1294757T3 (da) Glucagonlignende peptid 1-analoger
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
UY37680A (es) Proteína de fusión con polipéptido de extensión de vida media
TR199800956T1 (xx) Yeni �ndol-2, 3-diyon-3- oksim t�revleri.
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
PA8461601A1 (es) Isoquinolinas
CY1112822T1 (el) Ανταγωνιστης μορφογενετικων πρωτεϊνων οστων με βαση την ωριμη πρωτεϊνη
CY1109167T1 (el) Μεθοδος για την παρασκευη αυξητικης ορμονης και ανταγωνιστη αυτης εχοντας χαμηλοτερα επιπεδα ισομορφικων προσμειξεων αυτου
ES2075056T3 (es) Oxidasa de los d-aminoacidos.
ES2141819T3 (es) Ligandos del 5-ht1a.
NO970113D0 (no) Kollagenbindende protein eller polypeptid
ES2181015T3 (es) P-trifluormetilfeniluracilos substituidos.
ES2165410T3 (es) Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2176514T3 (es) Uso de derivados de perfluoroalquilo de aminoacidos como inhibidores de metalo-beta-lactamasa.
MX9207119A (es) Betun modificado utilizable dentro de una amplia escala de temperaturas y procedimiento para prepararlo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 646601

Country of ref document: ES